TipRanks
Go Ultimate75% OFF
Consano Bio Inc logo

Consano Bio Inc: Valuation, Funding & Investors

A clinical-stage biotechnology company developing novel therapeutics for serious, painful orthopedic conditions. Its lead investigational therapy, C-1101, is being advanced as a potential disease-modifying treatment for chronic painful lumbosacral radiculopathy.

Leadership & Board

Latest Estimated Valuation

Total Amount Raised
$15M
Total Funding Rounds
1
Latest Funding Amount
$15M
Latest Funding Round
Investment

Funding Round

Funding DateFunding RoundAmount RaisedPost-Money Valuation
Oct 05, 2026Investment$15.00M―

Investors

Investor NameFunding Round
Accredited private investorsInvestment

Similar Companies

A snapshot of private companies similar to Consano Bio Inc, helping you discover and navigate related company profiles.

Related News and Analysis